Literature DB >> 23939146

Adequate margin definition for scanned particle therapy in the incidence of intrafractional motion.

Antje-Christin Knopf1, Dirk Boye, Antony Lomax, Shininchiro Mori.   

Abstract

Advanced 4D dose calculations (4DDCs) for scanned particle therapy show that in the incidence of motion, it is insufficient to use target contours defined on one reference CT phase. ICRU Report 62 (ICRU 1999 ICRU Report 62 (Bethesda, MD: ICRU)) advises that variations in size, shape and position of CTVs relative to anatomic reference points have to be considered for internal target volumes (ITVs). In addition to geometrical margin adaption, changes of water equivalent path length have to be considered for particle therapy. Different ITV concepts have been applied to six representative patients (liver and lung indications) based on 4DCT. Geometrical ITVs (gITV) were calculated by combining deformed CTVs over all motion phases. To take into account path length changes, range adapted ITVs (raITV) were established as the union of range adapted CTVs in all phases. For gated delivery, gat_gITVs and gat_raITVs were calculated. Extensive 4DDCs have been performed for two exemplary patients to illustrate that neither re-scanning nor gating can sufficiently compensate for motion effects if no appropriate margins are employed and to evaluate the effectiveness of gITVs and raITVs. CTVs significantly differ from gITVs and raITVs in size (up to a factor 2 in volume). But also raITVs and gITVs differ significantly in size and are spatially displaced, particularly for lung patients. raITVs show a strong field dependence in shape. All volumes are reduced in size when gating is applied and considered during margin adaption. 4D dose distributions show big improvements when gITV or raITV are used compared to CTVs. However, the use of either gITVs or raITVs do not result in significant differences. If raITVs are used, slightly better target coverage is gained at the cost of more healthy tissue exposure. Our results emphasize that adapted target volumes have to be used for scanned particle therapy in the presence of motion. However, even though gITVs and raITVs differ significantly in shape and size, this difference does not necessarily translate into significant differences in the resultant 4D dose distributions.

Entities:  

Mesh:

Year:  2013        PMID: 23939146     DOI: 10.1088/0031-9155/58/17/6079

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  23 in total

1.  Motion mitigation for lung cancer patients treated with active scanning proton therapy.

Authors:  Clemens Grassberger; Stephen Dowdell; Greg Sharp; Harald Paganetti
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

2.  Four-dimensional layer-stacking carbon-ion beam dose distribution by use of a lung numeric phantom.

Authors:  Shinichiro Mori; Motoki Kumagai; Kentaro Miki
Journal:  Radiol Phys Technol       Date:  2015-04-02

3.  Gating window dependency on scanned carbon-ion beam dose distribution and imaging dose for thoracoabdominal treatment.

Authors:  Shinichiro Mori; Masataka Karube; Shigeo Yasuda; Naoyoshi Yamamoto; Hiroshi Tsuji; Tadashi Kamada
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

4.  Dose escalation study with respiratory-gated carbon-ion scanning radiotherapy using a simultaneous integrated boost for pancreatic cancer: simulation with four-dimensional computed tomography.

Authors:  Shohei Kawashiro; Shinichiro Mori; Shigeru Yamada; Kentaro Miki; Kenji Nemoto; Hiroshi Tsuji; Tadashi Kamada
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

5.  Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.

Authors:  Jie Shan; Yu An; Martin Bues; Steven E Schild; Wei Liu
Journal:  Med Phys       Date:  2017-12-05       Impact factor: 4.071

6.  How should we manage internal margins in four-dimensional dose assessments?

Authors:  Shinichiro Mori; Christian Graeff; Nobuyuki Kanematsu
Journal:  Radiol Phys Technol       Date:  2017-10-07

7.  Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Authors:  Wei Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Yu-Hui Chang; Zhifei Wen; Jiajian Shen; Joshua B Stoker; Xiaoning Ding; Yanle Hu; Narayan Sahoo; Michael G Herman; Carlos Vargas; Sameer Keole; William Wong; Martin Bues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-10       Impact factor: 7.038

Review 8.  Proton beam therapy for tumors of the upper abdomen.

Authors:  Ann Raldow; James Lamb; Theodore Hong
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

9.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

10.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.